FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, namely to the development of a hypoglycemic agent capable to increase exercise tolerance and to suppress appetite. Said agent represents an aqueous extract of Bergenia crassifolia fresh leaf which is dry-cured at temperature 50°C (desiccation approximately 30%), then crushed, fermented for 24-120 hours at temperature 20-45°C and dried before extraction.
EFFECT: agent extends the range of hypoglycemic drugs increasing exercise tolerance and suppressing appetite.
5 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ANORECTIC, HYPOGLYCEMIC AND HYPOLIPIDEMIC AGENT | 2009 |
|
RU2409379C1 |
| COMPOSITIONS FOR PROPHYLAXIS OR RELIEF OF MULTIPLE RISK FACTOR SYNDROMES | 2001 |
|
RU2291707C2 |
| AGENT WITH HYPOGLYCEMIC EFFECT, OBTAINED FROM RASPBERRY RHIZOMES AND ROOTS | 2022 |
|
RU2793328C1 |
| BIOLOGIALLY ACTIVE FOOD ADDITIVE "BADANIN" | 2008 |
|
RU2385648C1 |
| AGENT FOR TREATMENT OF ACUTE GASTROINTESTINAL DISEASES OF NEWBORN LAMBS | 2014 |
|
RU2574025C2 |
| AGENT FOR PREVENTING AND TREATING INSULIN-INDEPENDENT DIABETES | 2011 |
|
RU2458701C1 |
| "VITAPANT" BALSAM | 2008 |
|
RU2376891C1 |
| GYNOSTEMMA PENTAPHYLLUM COMPOSITION WITH HIGH PHARMACOLOGICAL ACTIVITY | 2013 |
|
RU2568883C2 |
| ACTOPROTECTION ACTION BEVERAGE | 2010 |
|
RU2423891C1 |
| COLLECTION OF MEDICINAL PLANTS OF NOOTROPIC ACTION | 2015 |
|
RU2578453C1 |
